申请人:AMGEN INC
                            
                            
                                公开号:WO2009085230A1
                            
                            
                                公开(公告)日:2009-07-09
                            
                            The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof, that inhibit phosphoinositide 3-kinase; Formula (I) methods of treating diseases or conditions, such as cancer, using the compounds; and pharmaceutical compositions containing the compounds.